(c) 2024 PillSync.com

Naproxen sodium 550 MG Oral Tablet

INDICATIONS AND USAGE Carefully consider the potential benefits and risks of naproxen sodium tablets and other treatment options before deciding to use naproxen sodium tablets. Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals ( see WARNINGS: Gastrointestinal Bleeding, Ulceration, and Perforation ). Naproxen sodium tablets are indicated: • For the relief of the signs and symptoms of rheumatoid arthritis • For the relief of the signs and symptoms of osteoarthritis • For the relief of the signs and symptoms of ankylosing spondylitis • For the relief of the signs and symptoms of juvenile arthritis Naproxen as naproxen suspension is recommended for juvenile rheumatoid arthritis in order to obtain the maximum dosage flexibility based on the patient’s weight. Naproxen sodium tablets are also indicated: • For relief of the signs and symptoms of tendonitis • For relief of the signs and symptoms of bursitis • For relief of the signs and symptoms of acute gout • For the management of pain • For the management of primary dysmenorrhea

Teva Pharmaceuticals USA Inc


4 years ago OVAL WHITE 93 537 Naproxen sodium 550 MG Oral Tablet

OVAL WHITE 93 537

4 years ago OVAL WHITE 93 537 Naproxen sodium 550 MG Oral Tablet

93 537 OVAL WHITE

HOW SUPPLIED Naproxen Sodium Tablets USP are supplied as follows: 275 mg: white, oval shaped, film-coated, unscored tablets, debossed "93" on one side and "536" on the other. They are available in bottles of 100 (NDC 0093-0536-01), 500 (NDC 0093-0536-05), and 1000 (NDC 0093-0536-10) tablets. 550 mg: white, oval shaped, film-coated, unscored tablets, debossed "93" on one side and "537" on the other. They are available in bottles of 100 (NDC 0093-0537-01), 500 (NDC 0093-0537-05), and 1000 (NDC 0093-0537-10) tablets. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured In Canada By: TEVA CANADA LIMITED Toronto, Canada M1B 2K9 Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 Rev. Q 5/2016


More pills like OVAL 93 537












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site